Table 2.
Other territories: authors’ experience of Pharmacovigilance System Master File (PSMF)-type documents required by local legislation
Document type | Description |
---|---|
Country/regional PSMF | Follows the same format as the EU PSMF but the content includes country/regional and global information on the PV system |
Country/regional Pharmacovigilance Sub-System File (PSSF) | Describes the key elements of PV activities in the country concerned and is submitted alongside the PSMF |
Detailed Description of the Pharmacovigilance System (DDPS) | Based on Volume 9A of the Rules Governing Medicinal Products in the European Union: Guidelines on Pharmacovigilance for Medicinal Products for Human Use requirements |
Provides a description of the system with requirements for listings and compliance data | |
Summary of the Pharmacovigilance System (SPS) | Terminology that, in the Authors’ experience, may have different meanings in different countries/regions. For example: |
a document based on EU GVP Module II requirements (proof of the applicant’s QPPV, residency and contact details of the QPPV, location of the PSMF and a signed statement that the applicant has the necessary means to fulfil the tasks and responsibilities listed in Title IX), or | |
a simple descriptive written summary of the PV System within a company | |
EU PSMF | Accepted where there are strong similarities with EU legislation/GVP. Of note, consideration should be given to the applicability of the EU PSMF content (e.g., responsibilities of the EU QPPV outside of this region) |
EU European Union, GVP good pharmacovigilance practices, PV pharmacovigilance, QPPV Qualified Person for Pharmacovigilance